ABSTRACT We describe a cytoplasmic steroid binding protein in the chick oviduct which has intriguing characteristics. This protein binds [3H]estradiol with high affinity (Kd = 30 x 10-9 M) and limited capacity (300 fmol/mg ofcytosol protein). It sediments at 8 S in low-salt sucrose density gradients and at 4 S in high-salt gradients. Unlike the estrogen receptor, however, this protein also binds progesterone, R5020, testosterone, and 5a-dihydrotestosterone with similar affinities and in a competitive manner. Moreover, it is not translocated to the nucleus by the in vivo administration of these sex steroids. The protein is only present in estrogen-responsive tissue, and like the sex steroid receptors, its synthesis appears to be regulated by estrogen.
Current molecular models of steroid hormone action suggest that these hormones initiate their regulatory effects by interacting with stereospecific receptor proteins localized in the cytosol oftarget tissues. Steroid hormone-receptor complexes are believed to undergo an energy-dependent activation (1) that results in a conformational change and translocation into the nucleus, where regulatory interactions with the genome occur (1) (2) (3) (4) . In the past few years, this well-accepted hypothesis has become complicated by the discovery of steroid receptor heterogeneity (5, 6) and the demonstration of multiple steroid binding proteins within target tissues (7, 8) . The role of these cytoplasmic hormone binding proteins is poorly understood, and the elucidation of their functions will be an important step in the understanding of steroid hormone action.
In addition to the classical estrogen receptor, Clark et al. (7) have reported the presence ofa secondary cytoplasmic estrogen binding molecule (type II) in the rat uterus. This protein does not translocate into the nucleus after estradiol treatment. Moreover, type II has an affinity for [3H] estradiol (Kd = 30 x 10-' M) considerably weaker than that of the classical rat uterus estrogen receptor (Kd = 0.8 x 10-9 M). A similar heterogeneity of estradiol binding molecules has been observed in mouse mammary cancer tissue (8) . In contradistinction to type I and type II estrogen binding proteins in rodent target tissue cytosol, we have reported that human uterus and chick oviduct cytosols contain two high-affinity estrogen binding proteins, both of which have the characteristics of receptors (5) . They have high affinities and specificity for estrogens, are present in limited cellular concentrations, and are found only in target tissue. Moreover, the chick oviduct estrogen receptors behave in sucrose gradients with characteristic profiles, translocate stoichiometrically from cytosol to nuclei in vivo, and appear to mediate a biological estrogenic response (9, 10) . Preliminary evidence in the human uterus suggests that each of these two receptors may have independent physiologic functions involved in the regulation ofmenstrual cyclicity (6) . For convenience, we refer to the two estrogen receptors as X and Y. the former representing the species with the higher affinity. This report describes the identification of a new estrogen binding protein, designated Z. MATERIALS AND METHODS Animals. Two-day-old White Leghorn pullets were purchased from Texas Animal Specialties (Humble, TX), provided with food and water ad lib, and raised in a constant temperature environment with a 13/11-hr light/dark schedule. At the chick age of 1 wk, estrogen stimulation was initiated by subcutaneous insertion of two silicone implants containing 25 mg of diethylstilbestrol (DES) each. Fourteen days after DES-implant insertion, the animals were considered fully stimulated. Periods of estrogen withdrawal, as indicated in the text, were begun after day 14 by removal ofthe DES implants through cutaneous incisions. In some experiments, chicks were injected subcutaneously 30 min before sacrifice with 2 mg each of estradiol, progesterone, and 5a-dihydrotestosterone in sesame oil. All animals were killed by decapitation; then the oviduct and spleen tissues were rapidly excised and processed immediately.
Hormones. [2, 4, 6, 7 -3H]Estradiol (90-100 Ci/mmol; 1 Ci = 3.7 X 101s becquerels), [1,2,6,7-3H] progesterone (89 Ci/ mmol), and [1,2,4,5,6,7-3H]5a-dihydrotestosterone (110 Ci/ mmol) were purchased from Amersham, and their purity was confirmed by thin-layer chromatography on silica gel plates. Unlabeled DES, estradiol, cortisol, progesterone, testosterone, and 5a-dihydrotestosterone were from Sigma. Tamoxifen was a gift from Stuart Pharmaceutical (Wilmington, DE). Promegestone (R5020) was purchased from New England Nuclear.
Chemicals. "Ultra-pure" Tris base, ammonium sulfate, and sucrose were obtained from Schwarz/Mann. Norit A charcoal, 1-thioglycerol, Scintiverse, and other analytical grade reagents were from Fisher. Dextran T 70 was from Pharmacia (Uppsala, Sweden). Bio-Rad supplied hydroxylapatite.
Preparation of Cytosol and Nuclear Extracts. Oviduct and spleen tissues isolated after hormonal stimulation or withdrawal were quickly excised, rinsed free ofdetectable blood in ice-cold 0.9% NaCl, and weighed. Cytosol and nuclear extracts were prepared as described (5) . To obtain receptor-depleted cytosol, oviducts were excised 30 min after treatment with 2.0 mg each of DES, dihydrotestosterone, and progesterone in sesame oil. Oviduct cytosols prepared from hens or hormone-stimulated chicks were treated with dextran-coated charcoal for 5 min at 40C to remove free steroids. The charcoal solution was prepared as described (5 [3H]Estradiol binding sites in purified whole nuclei were detected by using the nuclear exchange microassay as described (9) . Otherwise, separation of bound from free hormone was accomplished by dextran/charcoal or hydroxylapatite assays. These data were plotted as described by Scatchard (11) , providing estimates of the equilibrium dissociation constant, K& and concentration of binding sites, Nma. Complex Scatchard curves were resolved by the method ofRosenthal (12) . Cellular concentrations ofthe binding proteins were estimated on the basis of2.5 pg of DNA per chick cell nucleus (13) . DNA was quantitated by the diphenylamine method (14) .
Dextran-Coated Charcoal Adsorption Assay. This procedure was based on the method described by Korenman (15) and has been reported in detail by us (5).
Hydroxylapatite Adsorption Assay. A method modified from that of Erdos et al. (16) , which has been described in detail (5) was used. An alternative, more rapid assay was also used. The hydroxylapatite-bound receptor sample was washed with 3 ml of buffer on a glass-fiber filter with a Millipore apparatus under low suction. The filters containing hydroxylapatite-protein complexes were dried, extracted with ethanol, and assayed for radioactivity. Although the washing was performed more quickly in this manner, no differences in results were observed, suggesting that dissociation of the 3H-labeled ligand did not result in an underestimation of binding sites.
Enzymatic Digestion Experiments. Chick oviduct cytosol samples (0.2 ml) were incubated with 100 pug of trypsin, pancreatic RNase, or pancreatic DNase I per ml or with an equal volume of 10 mM Tris HCl, pH 7.4/1.5 mM EDTA/12 mM thioglycerol (TESH) containing only 5 mM MgCl2 (control) for 15 min at 23°C. These samples were then incubated with increasing concentrations of[3H]estradiol and unlabeled estradiol to titrate binding sites as described above. Displaceable hormone binding was determined by the dextran/charcoal assay.
Preparation of Purified Oviduct Plasma Membrane Fractions. Chick oviducts were finely minced and homogenized on ice in a glass/Teflon homogenizer (35 strokes) in 8 vol of 5 mM Tris HCl, pH 7.4 at 23°C/0.5 mM CaCl2/0.25 M sucrose. The homogenization and isolation protocol used had been shown to provide the highest specific activities of the plasma membrane markers 5'-nucleotidase and alkaline phosphatase (17) . Plasma membrane fractions were isolated and incubated for 2 hr at 40C with 3-60 nM [3H]estradiol in the absence and presence of excess unlabeled estradiol. Each sample was filtered through a nitrocellulose disc, with a Millipore apparatus to separate membrane-bound from free 3H-labeled ligand. Specific binding was examined by Scatchard analysis.
Sucrose Density Gradient Centrifugation. A modification of the postlabeling method of Clark et al. (7) was used. Chicks stimulated using silastic-containing implants containing 25 mg of DES were then treated with DES (2.5 mg), progesterone (2 mg), and dihydrotestosterone (2 mg) to deplete the oviduct of their respective receptors. After 30 min, the chicks were killed, oviduct cytosol was prepared, and 0.2 ml was applied to linear gradients of 5-20% sucrose in TESH or in TESH containing 0.4 M KCl. The gradients were prepared in 5 ml ofpolyallomer tubes (Beckman) using a Buchler Densiflow IIC gradient former (Ft. Lee, NJ). The tubes were centrifuged at 200,000 x g for 18 hr in a Beckman SW 50.1 rotor at 2-40C.
Each gradient was tapped from below and fractionated into 16 x 0.3 ml samples, which were directly collected into borosilicate glass tubes at 40C. Each glass tube contained 15 clearly showed that all were competitive inhibitors and that estradiol, progesterone, and dihydrotestosterone had identical inhibition constants (Fig. 2) . To ascertain whether Z was an artifact of [3H]estradiol binding to chick progestin or androgen receptors, we carried out Scatchard analyses ofoviduct cytosol with [3H]progesterone (89 Ci/mmol) and [3H]dihydrotestosterone (110 Ci/mmol). Our results demonstrated that the concentrations ofbinding sites of these two receptors differed from that ofZ and were 40,000 and 6,000 sites per cell, respectively, in agreement' with previous reports (26, 27) . The presence ofthese two receptors prohibited the quantitation of Z binding with radiolabeled progestins and androgens. However, when oviduct cytosol was isolated from chicks 30 min after the in vivo administration of 2 mg each of estrogen, dihydrotestosterone, and progesterone, Z was still present. Analyses of 0.4 M KC1 nuclear extracts and examination ofpurified oviduct nuclei isolated from chicks after sex steroid treatments failed to show Z binding activity. These results confirmed that unlike receptors, Z was not translocated into nuclear fractions.
It is generally assumed that steroid hormones passively diffuse across cellular membranes by virtue of their lipophilic nature. However, some reports indicate that their transport may Proc. Nad Acad. Scs in the presence of similar concentrations of RNase and DNase caused no depletion ofhormone binding. Therefore, the steroid binding moiety is protein in nature. The Z protein, like the sex steroid receptors, readily adsorbs to hydroxylapatite, indicating that its protein structure consists ofexposed acidic residues similar to receptor proteins. A further important similarity of Z to the steroid receptor molecule is its tissue specificity. Like the receptors, Z is confined to oviduct tissue and is undetectable in serum or in spleen cytosol. Postlabeled sucrose density gradient analysis of receptor-depleted cytosol, obtained from chicks treated with estrogen, progesterone, and dihydrotestosterone, was performed at low ionic strength and showed that Z sedimented predominately as an 8S complex (Fig. 3A) (Fig. 3B) .
These findings document a receptor-like steroid hormone binding protein in chick oviduct cytosol that has liberal hormone binding specificity. This protein (Z) binds estradiol, dihydrotestosterone, and progesterone with equal affinities. The characteristic ofmultispecific Z-ligand interactions implies that this protein may be a member of the "sterophilin" class, which we have described in other steroid hormone target tissues (t). It is ofinterest that an extravascular [3H]estradiol binding protein with characteristics very similar to Z was recently reported in the turtle oviduct (29) . This protein likewise sedimented at 7 S in low-salt sucrose gradients and bound testosterone, progesterone, and estradiol with equal affinities, albeit with an apparently lower Kd (2.7 x 10-9 M) than the Z Kd (30 X 10-9 M).
One possible physiological function of Z is that it regulates the intracellular concentrations of the sex steroids in the oviduct. It has been shown by Corvol and Bardin (30) that the chicken does not possess a plasma binding protein corresponding to the sex hormone binding globulin found in a number of mammalian species, which has molecular properties similar to those of Z because it also has a common binding site for testosterone, dihydrotestosterone, and estradiol. In the absence of a serum sex hormone binding globulin, it is conceivable that an intracellular binding protein such as Z might regulate the equilibrium between free and bound sex steroids, thus controlling the levels of these steroids interacting with their respective intracellular receptors. Furthermore, the presence of such a protein would provide an intracellular environment which would inhibit rapid metabolism of the sex steroids. A rapid metabolism of these plasma steroids would otherwise be expected to occur in the absence of sex hormone binding globulin.
Another possible role for the Z protein is that it might represent a common receptor precursor protein. Palmiter et aL (31) have demonstrated that estradiol, testosterone, and progesterone act synergistically to optimize oviduct cytodifferentiation and ovalbumin production in the hormone-stimulated chick. The synergism of these steroids also has been suggested in the ovulatory physiology of laying hens (32) . Estrogen, androgen, and progestin receptors have all been relatively well characterized in the chick oviduct, and their synthesis is amplified by the administration of estrogen (9, 26, 27, 33) . The converted into a true steroid hormone receptor, this precursor-product relationship is currently under investigation.
